Carga epidemiológica y económica de la hipertensión arterial en pacientes con síndrome metabólico en España: un modelo basado en la prevalencia

Patients with metabolic syndrome currently make up about one-fourth of the population with hypertension but account for nearly half the costs. The economic burden is likely to increase in the future due to an aging population and an increase in the prevalence of components of metabolic syndrome.